|
Index of reports
> Cases with Fall ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Femara (Letrozole) where reactions include fall. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Femara side effects in female
Reported by a physician from Germany on 2012-06-12
Patient: female
Reactions: Humerus Fracture, Wrist Fracture, Bone Density Decreased, Fall
Drug(s) suspected as cause:
Femara
Possible Femara side effects in 74 year old female
Reported by a pharmacist from Germany on 2012-06-07
Patient: 74 year old female
Reactions: Bone Pain, Dizziness, Fall, Hypertension, Hyperhidrosis
Drug(s) suspected as cause:
Femara
Other drugs received by patient: Apple Tree Mistletoe; Iscador
Possible Femara side effects in female
Reported by a pharmacist from United Kingdom on 2012-05-18
Patient: female
Reactions: Cervical Vertebral Fracture, Neck Pain, Laceration, Fall
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Femara
Possible Femara side effects in 75 year old female
Reported by a pharmacist from United Kingdom on 2012-04-05
Patient: 75 year old female
Reactions: Cervical Vertebral Fracture, Fall
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Femara
Possible Femara side effects in female
Reported by a consumer/non-health professional from Germany on 2012-02-13
Patient: female
Reactions: Humerus Fracture, Wrist Fracture, Bone Density Decreased, Fall
Drug(s) suspected as cause:
Femara
Possible Femara side effects in female
Reported by a consumer/non-health professional from Japan on 2012-02-06
Patient: female
Reactions: Night Sweats, Pain in Extremity, Anaemia, Hypoaesthesia, Fall, Facial Bones Fracture, Musculoskeletal Stiffness, Blood Pressure Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Femara
Administration route: Oral
Possible Femara side effects in 60 year old female
Reported by a physician from United States on 2012-01-18
Patient: 60 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Femur Fracture, Tooth Extraction, Hand Fracture, Post Procedural Haematoma, Fracture Nonunion, Fall, Osteoporosis Postmenopausal, Poor Quality Sleep, Foot Fracture, Myalgia, Postoperative Wound Infection, Arthropathy, Haematocrit Decreased, Drug Administration Error, Bone Density Decreased, Bone Disorder, LOW Turnover Osteopathy, Migraine, Intervertebral Disc Protrusion, Lumbar Radiculopathy, Skin Disorder, Appendix Disorder, Osteoarthritis, Haemoglobin Decreased, Rhinitis Allergic, Staphylococcal Infection, Salmonellosis, Tooth Disorder, Metastases To Bone
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Fosamax
Administration route: Oral
Start date: 2004-03-24
End date: 2008-01-01
Alendronate Sodium
Administration route: Oral
Indication: Osteoporosis Prophylaxis
Start date: 2008-03-17
End date: 2009-05-01
Fosamax
Administration route: Oral
Start date: 2004-03-24
End date: 2008-01-01
Fosamax
Administration route: Oral
Indication: Osteoporosis
Start date: 2003-10-01
End date: 2009-08-01
Femara
Indication: Breast Cancer
Start date: 2006-10-01
End date: 2007-05-01
Fosamax
Administration route: Oral
Indication: Osteoporosis Prophylaxis
Start date: 2003-10-01
End date: 2009-08-01
Alendronate Sodium
Administration route: Oral
Indication: Osteoporosis
Start date: 2008-03-17
End date: 2009-05-01
Other drugs received by patient: Effexor; Tamoxifen Citrate
Possible Femara side effects in 80 year old female
Reported by a consumer/non-health professional from United States on 2012-01-17
Patient: 80 year old female
Reactions: Blood Cholesterol Abnormal, Head Injury, Blood Pressure Systolic Increased, Osteoporosis, Fall, Hepatic Enzyme Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Femara
Other drugs received by patient: Diovan
Possible Femara side effects in 70 year old female
Reported by a physician from France on 2012-01-11
Patient: 70 year old female
Reactions: Malaise, Chest Discomfort, Respiratory Disorder, Hypotonia, Hearing Impaired, Visual Pathway Disorder, Fall, Chronic Obstructive Pulmonary Disease, Eructation
Drug(s) suspected as cause:
Femara
Administration route: Oral
Indication: Breast Cancer
Start date: 2006-01-01
End date: 2011-09-01
Boniva
Dosage: 1 unit monthly
Administration route: Oral
Indication: Osteoporosis
Start date: 2007-04-01
Indapamide
Administration route: Oral
Indication: Hypertension
Atorvastatin Calcium
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2008-08-01
Piascledine
Administration route: Oral
Indication: Osteoarthritis
Xyzal
Dosage: 1 unit in spring
Administration route: Oral
Indication: Seasonal Allergy
Voltaren
Dosage: for 5 or 6 days
Administration route: Oral
Indication: Osteoarthritis
Moviprep
Dosage: 1 unit daily
Administration route: Oral
Indication: Constipation
Other drugs received by patient: Spiriva
Possible Femara side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-06
Patient: female
Reactions: Malaise, Dyspnoea, Hypotonia, Visual Impairment, Hearing Impaired, Fall, Sense of Oppression, Eructation
Drug(s) suspected as cause:
Piascledine
Dosage: unk ukn, unk
Administration route: Oral
Indication: Osteoarthritis
Moviprep
Dosage: 1 df, qd
Administration route: Oral
Indication: Constipation
Xyzal
Dosage: 1 df, qd
Administration route: Oral
Indication: Seasonal Allergy
Voltaren
Dosage: 50 mg, tid
Administration route: Oral
Indication: Osteoarthritis
Femara
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Breast Cancer
Start date: 2006-01-01
End date: 2011-09-01
Indapamide
Dosage: 2 mg/0.625 mg, qd
Administration route: Oral
Indication: Hypertension
Atorvastatin Calcium
Dosage: 10 mg, qd
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2008-08-01
Boniva
Dosage: 1 df, qmo
Administration route: Oral
Indication: Osteoporosis
Start date: 2007-04-01
Other drugs received by patient: Spiriva
Possible Femara side effects in 60 year old female
Reported by a physician from United States on 2011-12-09
Patient: 60 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Femur Fracture, Tooth Extraction, Hand Fracture, Post Procedural Haematoma, Fracture Nonunion, Fall, Osteoporosis Postmenopausal, Foot Fracture, Poor Quality Sleep, Myalgia, Postoperative Wound Infection, Haematocrit Decreased, Drug Administration Error, Bone Disorder, Bone Density Decreased, LOW Turnover Osteopathy, Migraine, Skin Disorder, Lumbar Radiculopathy, Appendix Disorder, Osteoarthritis, Haemoglobin Decreased, Rhinitis Allergic, Staphylococcal Infection, Salmonellosis, Tooth Disorder
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Fosamax
Administration route: Oral
Indication: Osteoporosis
Start date: 2003-10-01
End date: 2009-08-01
Fosamax
Administration route: Oral
Start date: 2004-03-24
End date: 2008-01-01
Alendronate Sodium
Administration route: Oral
Indication: Osteoporosis
Start date: 2008-03-17
End date: 2009-05-01
Fosamax
Administration route: Oral
Indication: Osteoporosis Prophylaxis
Start date: 2003-10-01
End date: 2009-08-01
Fosamax
Administration route: Oral
Start date: 2004-03-24
End date: 2008-01-01
Femara
Indication: Breast Cancer
End date: 2007-05-01
Alendronate Sodium
Administration route: Oral
Indication: Osteoporosis Prophylaxis
Start date: 2008-03-17
End date: 2009-05-01
Other drugs received by patient: Effexor; Tamoxifen Citrate
Possible Femara side effects in 60 year old female
Reported by a physician from United States on 2011-11-18
Patient: 60 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Femur Fracture, Hand Fracture, Post Procedural Haematoma, Fall, Fracture Nonunion, Osteoporosis Postmenopausal, Foot Fracture, Poor Quality Sleep, Myalgia, Haematocrit Decreased, Postoperative Wound Infection, Drug Administration Error, Bone Disorder, Bone Density Decreased, LOW Turnover Osteopathy, Migraine, Lumbar Radiculopathy, Skin Disorder, Appendix Disorder, Osteoarthritis, Haemoglobin Decreased, Rhinitis Allergic, Staphylococcal Infection, Salmonellosis, Tooth Disorder
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Fosamax
Administration route: Oral
Indication: Osteoporosis Prophylaxis
Start date: 2003-10-01
End date: 2009-08-01
Fosamax
Administration route: Oral
Indication: Osteoporosis
Start date: 2003-10-01
End date: 2009-08-01
Femara
Indication: Breast Cancer
End date: 2007-05-01
Other drugs received by patient: Effexor; Tamoxifen Citrate
Possible Femara side effects in 60 year old female
Reported by a physician from United States on 2011-10-25
Patient: 60 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Femur Fracture, Hand Fracture, Post Procedural Haematoma, Fracture Nonunion, Fall, Osteoporosis Postmenopausal, Poor Quality Sleep, Foot Fracture, Myalgia, Haematocrit Decreased, Postoperative Wound Infection, Drug Administration Error, Bone Disorder, Bone Density Decreased, LOW Turnover Osteopathy, Migraine, Skin Disorder, Lumbar Radiculopathy, Appendix Disorder, Osteoarthritis, Haemoglobin Decreased, Rhinitis Allergic, Staphylococcal Infection, Salmonellosis
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Femara
Indication: Breast Cancer
End date: 2007-05-01
Fosamax
Administration route: Oral
Indication: Osteoporosis
Start date: 2003-10-01
End date: 2009-08-01
Fosamax
Administration route: Oral
Indication: Osteoporosis Prophylaxis
Start date: 2003-10-01
End date: 2009-08-01
Other drugs received by patient: Effexor; Tamoxifen Citrate
Possible Femara side effects in female
Reported by a physician from Germany on 2011-10-11
Patient: female, weighing 70.0 kg (154.0 pounds)
Reactions: Excoriation, Metastases To THE Mediastinum, Neoplasm Progression, General Physical Health Deterioration, Laceration, Metastatic Gastric Cancer, Fall, Arthropathy, Breast Cancer Metastatic, Neoplasm Malignant, Diarrhoea, Peritoneal Carcinoma Metastatic, Metastases To Bone
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Zometa
Dosage: 4 mg/5ml, every 4 weeks
Start date: 2011-09-21
Femara
Administration route: Oral
Indication: Breast Cancer
Zometa
Dosage: 4 mg/5ml, every 4 weeks
Start date: 2011-08-24
Zometa
Dosage: 4 mg/5ml, every 4 week
Indication: Prophylaxis
Start date: 2011-05-04
Other drugs received by patient: Torsemide; Kalinor-Brausetabletten; Marcumar; Naloxone; Spironolactone; Xipamide; Lisinopril; Enoxaparin; Taxol; Metoprolol Succinate; Pantoprazole
|
